Option Care Health (NASDAQ:OPCH) Sees Unusually-High Trading Volume on Strong Earnings

Option Care Health, Inc. (NASDAQ:OPCH) saw unusually-strong trading volume on Tuesday following a stronger than expected earnings report. Approximately 1,565,199 shares traded hands during mid-day trading, an increase of 27% from the previous session’s volume of 1,232,796 shares.The stock last traded at $30.46 and had previously closed at $30.41.

The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.04. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.21 earnings per share.

Analyst Ratings Changes

OPCH has been the subject of several recent analyst reports. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday. Jefferies Financial Group upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the business’s stock in a transaction on Monday, February 26th. The shares were purchased at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the purchase, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Principal Securities Inc. bought a new position in shares of Option Care Health during the fourth quarter worth about $27,000. Parallel Advisors LLC grew its stake in shares of Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 478 shares in the last quarter. TFO Wealth Partners LLC raised its holdings in shares of Option Care Health by 24,625.0% in the fourth quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after purchasing an additional 985 shares during the last quarter. Park Place Capital Corp lifted its position in shares of Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after purchasing an additional 372 shares in the last quarter. Finally, First Horizon Advisors Inc. acquired a new position in Option Care Health during the third quarter worth $37,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Down 2.1 %

The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33. The business’s 50-day moving average is $32.04 and its two-hundred day moving average is $31.50. The firm has a market cap of $5.09 billion, a P/E ratio of 19.27, a P/E/G ratio of 1.74 and a beta of 1.22.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.